Robot takes the scalpel: new study tests hugo system for cancer surgeries
NCT ID NCT05696444
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well a new robotic surgery system (Medtronic Hugo) works for urologic procedures like removing prostate, bladder, or kidney tumors. About 144 adults will have surgery with the robot, and doctors will check if the surgery is completed without switching to another method and track any complications within 30 days. The goal is to see if the system is safe and effective for these common cancer surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Duke Medical Center
Durham, North Carolina, 27710, United States
-
Mount Sinai
New York, New York, 10029, United States
-
Swedish Medical Center
Seattle, Washington, 98122, United States
-
University of Chiago
Chicago, Illinois, 60612, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- Can a Bag-Like device pull bladder tumors out whole?
- A second look: MRI screening may spot hidden prostate cancers
- Can a new drug work safely in patients with kidney failure?
- Can Pre-Surgery chemotherapy outsmart aggressive bladder cancer?